Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
ABBV
AbbVie Inc.
NYSE · Pharmaceutical Preparations
Last close
$272.42
· 2026-10-08
ABOUT
Exchange
NYSE
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$462.26B
RECENT INSIDER TRADES
2026-08-18
· Donoghoe Nicholas
(EVP, CHIEF BUS/STRAT OFFICER)
· OTHER
2026-08-18
· Donoghoe Nicholas
(EVP, CHIEF BUS/STRAT OFFICER)
· SELL
2026-05-12
· FREYMAN THOMAS C
(Director)
· OTHER
2026-05-12
· WADDELL FREDERICK H
(Director)
· OTHER
2026-05-12
· MEYER MELODY B
(Director)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
4,628
Shares held
1,685,239,652
Value
$395.33B
Percent of shares outstanding
95.37%
As of quarter end
2026-09-30
RECENT CONGRESSIONAL TRADES
2026-09-14
· Hon. Pete Sessions · SELL
· $15,001 - $50,000
2026-05-05
· Josh Gottheimer · SELL
· $1,001 - $15,000
2026-05-01
· Ro Khanna · BUY
· $15,001 - $50,000
2026-03-27
· Alan Armstrong · BUY
· $15,001 - $50,000
2025-12-18
· Hon. Julie Johnson · SELL
· $1,001 - $15,000
RECENT NEWS
AbbVie options flow shows 4:1 call-to-put ratio as stock rises
AbbVie's Temab-A receives two FDA breakthrough therapy designations
Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, more
AbbVie, Genmab's Epkinly sets ‘new standard of care’ in first-line lymphoma in Phase 3
UBS reiterates Abbvie stock rating on positive cancer trial data
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
AbbVie Inc. (ABBV) · Stock Price, Insider Trades, Congress Trades · CatalystPit